edetic acid has been researched along with 1,2-dicapryl-sn-3-glycerophosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, GC; Costantino, HR; Foerder, CA; Leonard, AK; Quay, SC; Sileno, AP | 1 |
1 other study(ies) available for edetic acid and 1,2-dicapryl-sn-3-glycerophosphocholine
| Article | Year |
|---|---|
In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.
Topics: Administration, Intranasal; Administration, Oral; Analysis of Variance; Animals; beta-Cyclodextrins; Biological Availability; Cell Membrane Permeability; Cells, Cultured; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Compounding; Edetic Acid; Electric Impedance; Epithelial Cells; Excipients; Factor Analysis, Statistical; Ferrets; Galantamine; Humans; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Tight Junctions; Vomiting | 2007 |